A carregar...
Publicação
Pairs trade in the pharmaceutical industry - the standpoint on bristol myers squibb
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.36 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
Investing in pharmaceutics presents lucrative opportunities, with high profit margins, due to
patent exclusivity, substantial investments in R&D, robust M&A activity and relatively stable
demand, even in economic downturns. The pharmaceutical industry experienced a boost in
revenues due to its response to Covid-19. However, as the pandemic has subsided, sales have
drastically decreased. Drug patents approaching the end of their exclusivity represent another
issue to be dealt with. Nonetheless, industry’s sales are predicted to rise given unmet medical
needs and population’s continuous growth, contributing to the industry’s appeal for careful
analysis and investment consideration, such as a pairs trade investment strategy.
Descrição
Palavras-chave
Valuation Terminal value Price target Investment strategy Pharmaceutical industry Performance Market analysis